Cellectar Biosciences (CLRB) Stock: Gaining On CLR 131 Update

Cellectar Biosciences CLRB Stock News

Cellectar Biosciences Inc (NASDAQ: CLRB) is having an incredibly strong start to the trading session this morning, and for good reason. The company provided an update with regard to its lead candidate, CLR 131. Of course, the update excited investors, pushing the stock up. Today, we’ll talk about: The CLR 131 update; what we’re seeing … Read more

Cellectar Biosciences (CLRB) Stock: Gaining On Fast Track Designation

Cellectar Biosciences CLRB Stock News

Cellectar Biosciences Inc (NASDAQ: CLRB) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it has been granted Fast Track Designation by the FDA, exciting investors and sending the stock for the top. Today, we’ll talk about: The Fast Track Designation; what we’re seeing … Read more

Cellectar Biosciences (CLRB) Stock: A Compelling Opportunity In The Making

Cellectar Biosciences CLRB Stock News

The oncology space is one that is undergoing a rapid evolution. With nearly 600,000 deaths per year, cancer is the second leading cause of death in the United States, and it has the attention of world class researchers internationally. This innovation in medicine has led to more treatment options than ever before, but it’s not … Read more

Cellectar Biosciences (CLRB) Stock: Rocketing On FDA News

Cellectar Biosciences CLRB Stock News

Cellectar Biosciences Inc (NASDAQ: CLRB) is flying early on in the trading session this morning, and for good reason. The company announced news with regard to an Import Alert exemption, exciting investors and sending the stock screaming for the top. Today, we’ll talk about: The granted exception; what we’re seeing from CLRB stock as a … Read more

Synthetic Biologics (SYN) Stock: The Run Is Done Here’s Your Next Opportunity

Synthetic Biologics Inc (NYSEAMERICAN: SYN) has seen incredible gains in the market as of late. While the company has released no recent news, there is a reason for the gains. Unfortunately however, I believe that we’ve reached the end of the line here. Nonetheless, there is another opportunity out there that may make SYN gains … Read more

Cellectar Biosciences (CLRB) Stock: There’s Still Room Here

Cellectar Biosciences Inc (NASDAQ: CLRB) has had an incredible run in the market over the past several trading sessions, capping of the gains with yesterday’s close over 24% higher than the close on Tuesday. Nonetheless, if you think you’ve missed the boat, think again. Today, we’ll talk about: Why the stock is running and why … Read more

Cellectar Biosciences (CLRB) Stock: Climbing On FDA News

Cellectar Biosciences Inc (NASDAQ: CLRB) is having an incredibly strong start to the trading session this morning, flying on high volume. The gains are coming for good reason. News broke this morning surrounding a designation the company received from the FDA for CLR-131. Of course, the news was positive, leading to excitement among investors and … Read more

Cellectar Biosciences (CLRB) Stock: Headed Up On Orphan Drug Designation

Cellectar Biosciences Inc (NASDAQ: CLRB) was having a pretty flat day in the market early on today. However, minutes ago, the company announced that its flagship candidate has been granted Orphan Drug Designation from the United States Food and Drug Administration (FDA). Today, we’ll talk about: The Orphan Drug Designation; what we’re seeing from the … Read more